Skip to main content

Month: March 2021

Pacific Health Care Organization, Inc. Reports its 2020 Year-End Financial Results

Newport Beach, March 31, 2021 (GLOBE NEWSWIRE) —  Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its annual report on Form 10-K announcing financial results for the fiscal year ended December 31, 2020. Results The Company reported total revenue of $6,042,718 for the year ended December 31, 2020, compared to $7,330,940 for the year ended December 31, 2019. The Company reported net income of $549,570 or $0.04 per basic and fully diluted shares for the year ended December 31, 2020, compared to net income of $1,198,060 or $0.09 per basic and fully diluted share for the year ended December 31, 2019. Net cash provided by operating activities was $987,441 during the year ended December 31, 2020, compared to $1,090,825 for the same period in...

Continue reading

Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results

PALATINE, Ill., March 31, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications, announced today financial results for the three and twelve months ended December 31, 2020. The Company reported an operating loss of $0.1 million for the fourth quarter 2020 compared to an operating income of $0.3 million for the same period in 2019. For the twelve months ended December 31, 2020, the Company reported an operating loss of $0.8 million compared to an operating loss of $0.7 million for the same period in 2019. Included in expenses for the results for 2020 was a one-time charge of $668 thousand to recognize an impairment in our Aversion intangible asset. The...

Continue reading

MAG Silver Reports 2020 Annual Results

VANCOUVER, British Columbia, March 31, 2021 (GLOBE NEWSWIRE) — MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or the “Company”) announces the Company’s audited consolidated financial results for the year ended December 31, 2020. For details of the audited consolidated financial statements, Management’s Discussion and Analysis, Annual Information Form and Annual Report on Form 40-F for the year ended December 31, 2020, please see the Company’s filings on SEDAR (www.sedar.com) or on EDGAR (www.sec.gov). All amounts herein are reported in $000s of United States dollars (“US$”) unless otherwise specified. HIGHLIGHTS – DECEMBER 31, 2020 AND SUBSEQUENT TO YEAR END OPERATIONALProcessing of mineralized material from development headings through the nearby Fresnillo plant was a new initiative at Juanicipio implemented in August...

Continue reading

Fortress Biotech Reports Record 2020 Financial Results and Recent Corporate Highlights

Revenue from marketed dermatology products increased 28% for full-year 2020 compared to 2019 Our partner company, Cyprium Therapeutics, and Sentynl Therapeutics, a wholly-owned subsidiary of the Zydus Group, signed a Development and Asset Purchase Agreement for CUTX-101 for the treatment of Menkes disease Rolling NDA submission for CUTX-101 for the treatment of Menkes disease is expected to begin in the second half of 2021 NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, today announced financial results and recent corporate highlights for the full-year ended December 31, 2020. Lindsay A. Rosenwald, M.D.,...

Continue reading

Inspire Medical Systems, Inc. Announces FDA Approval and Commercial Launch of New Physician Programmer Platform

MINNEAPOLIS, March 31, 2021 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced receipt of U.S. Food and Drug Administration (“FDA”) approval for the new Inspire physician programmer platform. The most significant enhancement associated with this approval is the new telemetry cable which enables Bluetooth® connectivity to the programmer tablet. “In addition to the recently announced approval for the Inspire two-incision procedure, the launch of our new physician programmer platform further demonstrates our long-term commitment to patients through Inspire’s continued investment in our innovative technologies,” said...

Continue reading

MAG Silver Announces the Appointment of Tim Baker as a Director

VANCOUVER, British Columbia, March 31, 2021 (GLOBE NEWSWIRE) — MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or the “Company”) is pleased to announce that Mr. Tim Baker has joined the Company as a member of the Board of Directors.    Mr. Baker has a B.Sc. in Geology from Edinburgh University and has substantial experience in operating international mines and projects. He was Executive Vice President and Chief Operating Officer of Kinross Gold Corporation prior to retiring in 2010. Prior to joining Kinross, he was with Placer Dome, where he held several key roles including Executive General Manager of Placer Dome Chile, Executive General Manager of Placer Dome Tanzania and Senior Vice President of the copper producing Compañia Minera Zaldivar. Mr. Baker is currently Chair of Golden Star Resources, a director of Sherritt International...

Continue reading

Palomar Holdings, Inc. Sponsors Torrey Pines Re Catastrophe Bond

LA JOLLA, Calif., March 31, 2021 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or the “Company”) today announced that through its wholly-owned subsidiaries, Palomar Specialty Insurance Company (“Palomar Specialty”) and Palomar Excess and Surplus Insurance Company (“PESIC”), the Company has successfully closed a $400 million 144A catastrophe bond completed through Torrey Pines Re Pte. Ltd. (“Torrey Pines Re”). Palomar entered into a multi-year reinsurance arrangement with Torrey Pines Re, a special purpose insurer established in Singapore whereby Torrey Pines Re provides Palomar with indemnity-based reinsurance covering earthquake events. The catastrophe bond was designed to seamlessly fit into Palomar’s existing traditional catastrophe reinsurance program. Torrey Pines Re issued two tranches of notes as part...

Continue reading

Applied Materials to Detail Plans for Helping Accelerate Customer Success in the AI Era

SANTA CLARA, Calif., March 31, 2021 (GLOBE NEWSWIRE) — Applied Materials, Inc. will host its 2021 Investor Meeting this coming Tuesday, April 6. Company leaders will detail plans and unique capabilities designed to help customers accelerate their technology roadmaps and growth in the AI era. The meeting will detail innovative solutions Applied is developing and delivering to drive continued improvements in the power, performance, area-cost and time to market (PPACt) of semiconductors and systems as traditional Moore’s Law 2D scaling slows. The company will also provide updates on its financial outlook and key initiatives including its environmental, social and governance (ESG) programs. The meeting will feature presentations from company executives along with insights from many of Applied’s leading customers and partners. Presenters:Gary...

Continue reading

Full House Resorts Announces $15.0 Million Senior Secured Revolving Credit Facility

LAS VEGAS, March 31, 2021 (GLOBE NEWSWIRE) — Full House Resorts, Inc. (Nasdaq: FLL) announced today that it has entered into an agreement for a five-year, senior secured revolving credit facility. The $15.0 million credit facility may be used for working capital, letters of credit, and other ongoing general purposes. Until the completion of the Company’s Chamonix project in Cripple Creek, Colorado, the interest rate per annum applicable to loans under the credit facility will be, at the Company’s option, either (i) LIBOR plus a margin equal to 3.50%, or (ii) a base rate plus a margin equal to 2.50%. After completion of Chamonix (as defined in the credit agreement), the interest rate per annum applicable to loans under the credit facility reduces to, at the Company’s option, either (i) LIBOR plus a margin equal to 3.00%, or (ii) a...

Continue reading

Sportsman’s Warehouse Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results

WEST JORDAN, Utah, March 31, 2021 (GLOBE NEWSWIRE) — Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”) (Nasdaq: SPWH) today announced financial results for the thirteen and fifty-two weeks ended January 30, 2021. “Sportsman’s Warehouse finished fiscal 2020 with record performance for the fourth quarter and full year. I am proud of our associates who made tremendous efforts to safely serve our customers,” said Jon Barker, Sportsman’s Warehouse CEO. “Fourth quarter same store sales increased 58% compared to the same period last year due to an exceptionally strong holiday season, elevated participation in outdoor activities, and our continued market share gains in firearms. For fiscal year 2020, we grew same store sales by 48% compared to the prior year as we capitalized on historic...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.